Published in Facial Plast Surg on January 01, 1999
The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.96
Risk factors for malignancy in adult tonsils. Head Neck (1998) 1.44
Recurrent benign parotid tumours: the lesson not learned yet: comment. Aust N Z J Surg (1999) 1.38
Quantification of surgical margin shrinkage in the oral cavity. Head Neck (1997) 1.26
Acute airway compromise secondary to traumatic thyroid hemorrhage. Arch Otolaryngol Head Neck Surg (1994) 1.04
Osseointegrated implants: a comparative study of bone thickness in four vascularized bone flaps. Plast Reconstr Surg (1993) 1.04
Chondroid syringoma of the head and neck: clinical management and literature review. Ear Nose Throat J (1996) 1.04
The nasogastric tube syndrome: two case reports and review of the literature. Head Neck (2001) 1.00
Midline anterior craniofacial approach for malignancy: results of en bloc versus piecemeal resections. Skull Base Surg (1999) 0.99
Pectoralis major myofascial flap: a valuable tool in contemporary head and neck reconstruction. Head Neck (1997) 0.97
Role of radiotherapy in adenoid cystic carcinoma of the head and neck. J Laryngol Otol (2009) 0.93
Patterns of metastases to the upper jugular lymph nodes (the "submuscular recess"). Head Neck (1998) 0.91
Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg (1998) 0.91
Are head and neck specific quality of life measures necessary? Head Neck (1997) 0.88
Management of displaced lateral orbital wall fractures associated with visual and ocular motility disturbances. Plast Reconstr Surg (1998) 0.87
Preoperative assessment of obstruction with computed tomography image analysis. Am J Otolaryngol (2000) 0.87
Assessing head and neck cancer patient outcome domains. Head Neck (2000) 0.87
The fibula osteocutaneous flap in head and neck reconstruction: a critical evaluation of donor site morbidity. Arch Otolaryngol Head Neck Surg (2000) 0.87
Reconstruction of the pediatric maxilla and mandible. Arch Otolaryngol Head Neck Surg (2000) 0.84
Resource utilization and patient morbidity in head and neck reconstruction. Laryngoscope (1997) 0.78
Rigid internal fixation for fractures involving tooth-bearing maxillary segments. Arch Otolaryngol Head Neck Surg (1988) 0.78
Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges. Laryngoscope (2000) 0.78
Titanium osseointegrated implants combined with hyperbaric oxygen therapy in previously irradiated mandibles. J Prosthet Dent (1997) 0.78
The use of granulocyte colony stimulating factor to promote wound healing in a neutropenic patient after head and neck surgery. Head Neck (1999) 0.77
The communicating vein and its use in the radial forearm free flap. Laryngoscope (1996) 0.77
Health states following head and neck cancer treatment: patient, health-care professional, and public perspectives. Head Neck (1998) 0.77
Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy. Laryngoscope (2000) 0.76
Quality of life measurements of speech in the head and neck cancer patient population. Head Neck (1999) 0.76
Botulinum neurotoxin injection after total laryngectomy. Head Neck (1997) 0.75
Associations between selected demographic parameters and dental status: potential implications for orodental rehabilitation. J Prosthet Dent (1998) 0.75
Impression technique for nonosseous free-tissue transfer reconstruction after cranioorbitomaxillary resection: A clinical report. J Prosthet Dent (1996) 0.75
Management of complicated fractures involving the orbits and nasoethmoid complex in young children. Otolaryngol Clin North Am (1991) 0.75
Resonance-enhanced Raman identification of a ternary chemical intermediate during the equine liver alcohol dehydrogenase reduction of p-(dimethylamino)benzaldehyde. Biochemistry (1982) 0.75
Intra-operative ultrasound-guided drainage of parotid abscess. J Laryngol Otol (1998) 0.75
Liver function studies in the assessment of head and neck cancer patients. Head Neck (1996) 0.75